ROUND ROCK, TEXAS – Cerilliant introduces two new Certified Spiking Solutions® of nicotine metabolites anabasine-D4 HCl and trans-3’-Hydroxycotinine-D3 at concentrations of 100 µg/mL in methanol. These solution standards can be used as internal standards spiked into patient samples or in isotope dilution methods for quantification of anabasine and 3-hydroxycotinine levels in nicotine screening and other […]
LAUSANNE, Switzerland — Spinomix SA, a Swiss company advancing molecular diagnostic through innovative sample preparation technologies and Debiopharm Group™(Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs including oncology as well as companion diagnostics, today announced the successful achievement of a second development milestone on Spinomix’ two proprietary technologies, namely […]
HOLLISTON, Mass. — Humans have always organized things. Something in our brains tells us to break information into smaller chunks, making it easier to understand. We separate animals into different species, books into genres and clothing into styles. In this era of endless medical specialization, our aptitude for grouping is more important than ever. For […]
FREMONT, Calif. — WaferGen Bio-systems, Inc. (QTCQB: WGBS) announced today the acquisition of the NGS library preparation business from IntegenX Inc. Pursuant to the asset purchase agreement, WaferGen Bio-systems, Inc., through Wafergen, Inc., its wholly owned subsidiary, acquired on January 6, 2014 substantially all of the assets of IntegenX’s product line used in connection with […]
INTEGRA announces the VIAFLO ASSIST – an innovative new device that, in combination with a VIAFLO II electronic handheld pipette, enables the pipette’s protocols to be performed automatically. This unique new product from INTEGRA reduces the need for traditional handheld pipetting to a minimum, relieving lab personnel from activities that may cause repetitive stress injuries. […]
CHALFONT ST. GILES, UK – GE (NYSE:GE) and Thermo Fisher Scientific (NYSE:TMO) announced today that they have entered into an agreement for GE Healthcare to acquire Thermo Fisher’s HyClone™ cell culture media and sera, and gene modulation and magnetic beads businesses for approximately $1.06 billion. The acquisition will allow GE to expand its offering of […]
MENLO PARK, Calif. — SRI International has received a $4.5 million contract from the National Heart, Lung and Blood Institute, part of the National Institutes of Health, to establish a Metabolite Standards Synthesis Center to prepare molecules for researchers to use in the emerging field of metabolomics. Like genomics and proteomics, which study the collective […]
WALTHAM, Mass. — Thermo Fisher Scientific (NYSE:TMO), the world leader in serving science, today announced that it has signed an agreement to sell its cell culture (sera and media), gene modulation and magnetic beads businesses to GE Healthcare, a unit of General Electric Company (NYSE: GE), for approximately $1.06 billion. The businesses will become part […]
MONMOUTH JUNCTION, N.J. — A requirement of massively parallel SNP analysis is to have high quality DNA suitable for target amplifications, and prepared economically from practical blood volumes. ProPrep™ Genomic is a blood DNA purification system based upon the unique protein binding reagent, ProCipitate™. Data is presented demonstrating as little as 1-2 ng of template […]
Porvair Sciences reports strong growing demand for their Chromatrap® chromatin immunoprecipitation (ChIP) assay technology from academic groups and biopharmaceutical organisations involved with epigenetic research. Stephen Knight, Sales and Marketing Director commented “An expanding number of proven application solutions and the introduction of the Chromatrap® 96 HT solid-state ChIP high throughput platform has enabled us to […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
